- Best Practices New Normal
- Digital Dentistry
- Data Security
- Implants
- Catapult Education
- COVID-19
- Digital Imaging
- Laser Dentistry
- Restorative Dentistry
- Cosmetic Dentistry
- Periodontics
- Oral Care
- Evaluating Dental Materials
- Cement and Adhesives
- Equipment & Supplies
- Ergonomics
- Products
- Dentures
- Infection Control
- Orthodontics
- Technology
- Techniques
- Materials
- Emerging Research
- Pediatric Dentistry
- Endodontics
- Oral-Systemic Health
Ivoclar Vivadent brings back Just Cure It!
Ivoclar Vivadent announces that for the second year, $100 will be donated to breast cancer research for each pink Bluephase® Style curing light sold during the month of October. In honor of Breast Cancer Awareness month, Ivoclar Vivadent employees will also be supporting the cause by participating in the Susan B. Komen Race for the Cure.
Ivoclar Vivadent announces that for the second year, $100 will be donated to breast cancer research for each pink Bluephase® Style curing light sold during the month of October. In honor of Breast Cancer Awareness month, Ivoclar Vivadent employees will also be supporting the cause by participating in the Susan B. Komen Race for the Cure.
“Our award-winning Bluephase® LED curing lights provide a great resource for dental practices, and we at Ivoclar Vivadent believe that donating a portion of the proceeds to Breast Cancer Research provides a great resource for finding a cure,” said Danny Forcucci, Marketing Manger for Bluephase® Curing Lights. “Now you can help us make a contribution toward Breast Cancer Research with the purchase of a pink Bluephase® Style light in the month of October.”
With Polywave™ technology, the Bluephase® Style LED curing light is the latest advancement in dental curing lights that efficiently cures all dental materials. Specially designed for easy access to posterior teeth, the Bluephase® Style can be used cordless or corded. Its slim design and intuitive two-button operation is lightweight and very small, making it the ideal curing light for any treatment.
According to the National Cancer Institute at the National Institutes of Health, approximately one in eight women will be diagnosed with breast cancer at some point during their lifetime. With more than 230,000 new cases each year, breast cancer is a serious and aggressive disease. By funding research, advances in diagnosis and treatment are possible. For more information, contact the National Cancer Institute at the National Institutes of Health at www.cancer.gov/cancertopics/types/breast, or by phone at 1-800-4-cancer.
Episode 31: Dentsply Sirona Implant Announcements
September 30th 2021DPR’s Editorial Director Noah Levine sat down with Gene Dorff, Dentsply Sirona’s group vice president of implants and Dr. Dan Butterman to review several big announcements the company made in the arena of implants during Dentsply Sirona World 2021 in Las Vegas.
Crest Toothpaste Honored as National Historic Chemical Landmark
April 10th 2024The American Chemical Society has designated Crest toothpaste as a National Historic Chemical Landmark, recognizing its introduction in 1955 as a transformative moment in dental care through the incorporation of fluoride chemistry.
